MBBS (S’pore), M Med (Int Med), MRCP (UK), Dip Palliative Med (Aus) Dr Lynette Ngo is a medical oncologist who specializes in women’s cancers – breast and gynaecologic cancers including ovary, endometrial, uterine and cervical cancers.
Dr Ngo graduated from National University of Singapore in 1996. She further pursued a Master of Medicine degree in Internal Medicine and obtained her membership of the Royal College of Physicians in UK in 2002. She received her post graduate Diploma in Palliative Medicine from Edith Cowan University in Australia in 2006 and obtained her specialist accreditation in medical oncology from the Academy of Medicine, Singapore in 2007. She is a member of the American Society of Clinical Oncology (ASCO), European Society of Clinical Oncology (ESMO), Asian Society of Gynaecologic Oncology (ASGO) and Singapore Society of Oncology (SSO). She serves on the Singapore Cancer Network (SCAN) guidelines committee. Prior to Curie Oncology, Dr Ngo had been practising at National Cancer Centre, Singapore (NCCS) from 2005 to 2012 before moving to Raffles Cancer Centre, Raffles Hospital from 2012 to 2019. Aside from being a Clinical Tutor at the Yong Loo Lin Medical School, she was also a Visiting Consultant to both KKWCH Gynaecologic Cancer Centre and KKWCH Breast Centre as well as to Khoo Teck Puat Hospital. In addition, she spent 5 years caring for patients in hospice home care and in-patient hospice services in the community prior to joining NCCS. Dr Ngo has also completed the Intensive Course in Cancer Risk Assessment at City of Hope Hospital in California, USA from Oct 2017 to Mar 2018. She established the Hereditary Cancer Risk assessment clinic and genetic counselling in Raffles Hospital.
Awards and publications
Dr Ngo’s areas of interest are in breast and gynaecologic cancers, hereditary cancers and genetic counselling, psychosocial oncology and palliative medicine, in addition to general medical oncology. In pursuing her sub-specialty interest in gynaecologic cancers, Dr Ngo was awarded the Health Manpower Development Programme Award to spend a year at the Gillette Center for Gynecologic Oncology at Massachusetts General Hospital (MGH), USA. In collaboration with the MGH gynaecologic oncology team, she designed and conducted several investigator-initiated clinical trials, testing novel drugs and treatment strategies in subsets of gynaecologic cancers with molecularly defined pathways. She had received a grant from the Singhealth Foundation for her research work and was involved in multiple clinical trials in Raffles Hospital focusing on breast and gynaecologic cancers. She has contributed to numerous publications in peer reviewed journals and written book chapters.